New patent for Ocular Therapeutix drug DEXTENZA

Annual Drug Patent Expirations for DEXTENZA Dextenza is a drug marketed by Ocular Therapeutix and is included in one NDA. It is available from one supplier. The generic ingredient in… The post New patent for Ocular Therapeutix drug DEXTENZA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!